Metabolic Syndrome and the Risk for Chronic Kidney Disease among Nondiabetic Adults
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The metabolic syndrome is a risk factor for the development of diabetes and cardiovascular disease; however, no prospective studies have examined the metabolic syndrome as a risk factor for chronic kidney disease (CKD). A total of 10,096 nondiabetic participants who were in the Atherosclerosis Risk in Communities study and had normal baseline kidney function composed the study cohort. The metabolic syndrome was defined according to recent guidelines from the National Cholesterol Education Program. Incident CKD was defined as an estimated GFR (eGFR) <60 ml/min per 1.73 m2 at study year 9 among those with an eGFR > or =60 ml/min per 1.73 m2 at baseline. After 9 yr of follow-up, 691 (7%) participants developed CKD. The multivariable adjusted odds ratio (OR) of developing CKD in participants with the metabolic syndrome was 1.43 (95% confidence interval [CI], 1.18 to 1.73). Compared with participants with no traits of the metabolic syndrome, those with one, two, three, four, or five traits of the metabolic syndrome had OR of CKD of 1.13 (95% CI, 0.89 to 1.45), 1.53 (95% CI, 1.18 to 1.98), 1.75 (95% CI, 1.32 to 2.33), 1.84 (95% CI, 1.27 to 2.67), and 2.45 (95% CI, 1.32 to 4.54), respectively. After adjusting for the subsequent development of diabetes and hypertension during the 9 yr of follow-up, the OR of incident CKD among participants with the metabolic syndrome was 1.24 (95% CI, 1.01 to 1.51). The metabolic syndrome is independently associated with an increased risk for incident CKD in nondiabetic adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The metabolic syndrome is also an independent indicator for chronic kidney disease [636] and may be related to liver steatosis [637].”
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
(1989) · PubMed · Cited by 3,139
THE ATHEROSCLEROSIS RISK IN COMMUNIT (ARIC) STUDY: DESIGN AND OBJECTIVES
THE ARIC INVESTIGATORS (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115184 · Cited by 2,924
Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50007 · Cited by 2,768
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
Chen, J., Muntner, P., Hamm, L. L., Jones, D. W., Batuman, V., Fonseca, V., Whelton, P. K., & He, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00007 · Cited by 1,359
Zatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112521 · Cited by 1,209
Cited by
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
National Health and Nutrition Examination Survey
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_6177 · Cited by 2,087
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D'Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman-Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 716
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Metabolic Syndrome and Kidney Disease: A Systematic Review and Meta-analysis
Thomas, G., Sehgal, A. R., Kashyap, S. R., Srinivas, T. R., Kirwan, J. P., & Navaneethan, S. D. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02180311 · Cited by 553
“Only four studies reported the use of creatinine calibration (10,13,14,25).”
BackgroundMethodInfluentialDiabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, B. E. K., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 515
Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease
de Vries, A. P. J., Ruggenenti, P., Ruan, X. Z., Praga, M., Cruzado, J. M., Bajema, I. M., D'Agati, V. D., Lamb, H. J., Barlovic, D. P., Hojs, R., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70065-8 · Cited by 500
Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease
Wahba, I. M., & Mak, R. H. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04071206 · Cited by 513
Uric Acid and Incident Kidney Disease in the Community
Weiner, D. E., Tighiouart, H., Elsayed, E. F., Griffith, J. L., Salem, D. N., & Levey, A. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101075 · Cited by 462
Fatty Kidney, Hypertension, and Chronic Kidney Disease: The Framingham Heart Study
Foster, M. C., Hwang, S.-J., Porter, S. A., Massaro, J. M., Hoffmann, U., & Fox, C. S. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.175315 · Cited by 356
Insulin-like growth factor-1 deficiency and metabolic syndrome
Aguirre, G. A., De Ita, J. R., de la Garza, R. G., & Castilla-Cortazar, I. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-015-0762-z · Cited by 295
Metabolic syndrome and chronic kidney disease
Singh, A. K., & Kari, J. A. (2013) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e32835dda78 · Cited by 298
Predicting initiation and progression of chronic kidney disease: Developing renal risk scores
Taal, M. W., & Brenner, B. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001794 · Cited by 282
A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study
Suleymanlar, G., Utas, C., Arinsoy, T., Ates, K., Altun, B., Altiparmak, M. R., Ecder, T., Yilmaz, M. E., Camsari, T., Basci, A., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq656 · Cited by 255
p-Cresyl Sulfate Promotes Insulin Resistance Associated with CKD
Koppe, L., Pillon, N. J., Vella, R. E., Croze, M. L., Pelletier, C. C., Chambert, S., Massy, Z., Glorieux, G., Vanholder, R., Dugenet, Y., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012050503 · Cited by 270
Low Urine pH: A Novel Feature of the Metabolic Syndrome
Maalouf, N. M., Cameron, M. A., Moe, O. W., Adams-Huet, B., & Sakhaee, K. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00670207 · Cited by 274
Insulin Resistance, Hyperinsulinemia, and Renal Injury: Mechanisms and Implications
Sarafidis, P. A., & Ruilope, L. M. (2006) · American Journal of Nephrology · doi:10.1159/000093632 · Cited by 272
Structural and functional changes in the kidneys of high-fat diet-induced obese mice
Deji, N., Kume, S., Araki, S.-I., Soumura, M., Sugimoto, T., Isshiki, K., Chin-Kanasaki, M., Sakaguchi, M., Koya, D., Haneda, M., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00110.2008 · Cited by 262
The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease
Odermatt, A. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00068.2011 · Cited by 257
Cardiovascular Disease and Subsequent Kidney Disease
Elsayed, E. F., Tighiouart, H., Griffith, J., Kurth, T., Levey, A. S., Salem, D., Sarnak, M. J., & Weiner, D. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.11.1130 · Cited by 255
Nagase, M., Yoshida, S., Shibata, S., Nagase, T., Gotoda, T., Ando, K., & Fujita, T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080944 · Cited by 248
HIV infection and coronary heart disease: mechanisms and management
Hsue, P. Y., & Waters, D. D. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0219-9 · Cited by 229
Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes
Porrini, E., Ruggenenti, P., Mogensen, C. E., Barlovic, D. P., Praga, M., Cruzado, J. M., Hojs, R., Abbate, M., & de Vries, A. P. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00094-7 · Cited by 232
Targher, G., Bertolini, L., Rodella, S., Lippi, G., Zoppini, G., & Chonchol, M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05050610 · Cited by 233
Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective
Zoccali, C. (2006) · Kidney International · doi:10.1038/sj.ki.5000417 · Cited by 236
Association of metabolic dysfunction-associated fatty liver disease with kidney disease
Wang, T.-Y., Wang, R.-F., Bu, Z.-Y., Targher, G., Byrne, C. D., Sun, D.-Q., & Zheng, M.-H. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00519-y · Cited by 210
De Cosmo, S., Menzaghi, C., Prudente, S., & Trischitta, V. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs290 · Cited by 219
CKD and Nonalcoholic Fatty Liver Disease
Targher, G., Chonchol, M. B., & Byrne, C. D. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.05.019 · Cited by 213
Fructose, but not dextrose, accelerates the progression of chronic kidney disease
Gersch, M. S., Mu, W., Cirillo, P., Reungjui, S., Zhang, L., Roncal, C., Sautin, Y. Y., Johnson, R. J., & Nakagawa, T. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00181.2007 · Cited by 217
Dyslipidemia and the progression of renal disease in chronic renal failure patients
Cases, A., & Coll, E. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09916.x · Cited by 211
The long-term renal and cardiovascular consequences of prematurity
Abitbol, C. L., & Rodriguez, M. M. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.38 · Cited by 197
(2011) · MEDICC Review · doi:10.37757/mr2011v13.n4.5 · Cited by 163
Thethi, T., Kamiyama, M., & Kobori, H. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0245-z · Cited by 178
The metabolic syndrome and chronic kidney disease
Zhang, X., & Lerman, L. O. (2017) · Translational Research · doi:10.1016/j.trsl.2016.12.004 · Cited by 173
Obesity and Diabetic Kidney Disease
Maric-Bilkan, C. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.10.010 · Cited by 173
Insulin Resistance in Patients with Chronic Kidney Disease
Liao, M.-T., Sung, C.-C., Hung, K.-C., Wu, C.-C., Lo, L., & Lu, K.-C. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/691369 · Cited by 165
Metabolic Syndrome and CKD in a General Japanese Population: The Hisayama Study
Ninomiya, T., Kiyohara, Y., Kubo, M., Yonemoto, K., Tanizaki, Y., Doi, Y., Hirakata, H., & Iida, M. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.06.003 · Cited by 181
Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?
Targher, G., Chonchol, M., Zoppini, G., Abaterusso, C., & Bonora, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.007 · Cited by 171
Renal and Extrarenal Actions of Klotho
Hu, M. C., Kuro-o, M., & Moe, O. W. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.12.013 · Cited by 172
Increased risk of cardiovascular disease and chronic kidney disease in NAFLD
Bonora, E., & Targher, G. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.79 · Cited by 169
Devuyst, O., Ahn, C., Barten, T. R. M., Brosnahan, G., Cadnapaphornchai, M. A., Chapman, A. B., Gall, É. C.-L., Drenth, J. P. H., Gansevoort, R. T., Harris, P. C., et al. (2025) · Kidney International · doi:10.1016/j.kint.2024.07.009 · Cited by 177
Metabolic syndrome and chronic kidney disease: Current status and future directions
Prasad, G. R. (2014) · World Journal of Nephrology · doi:10.5527/wjn.v3.i4.210 · Cited by 161
de Boer, I. H., Sibley, S. D., Kestenbaum, B., Sampson, J. N., Young, B., Cleary, P. A., Steffes, M. W., Weiss, N. S., & Brunzell, J. D. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040394 · Cited by 165
Chang, Y., Ryu, S., Sung, E., Woo, H.-Y., Oh, E., Cha, K., Jung, E., & Kim, W. S. (2008) · Metabolism · doi:10.1016/j.metabol.2007.11.022 · Cited by 164
Association between the metabolic syndrome and chronic kidney disease in Chinese adults
Chen, J., Gu, D., Chen, C.-S., Wu, X., Hamm, L. L., Muntner, P., Batuman, V., Lee, C.-H., Whelton, P. K., & He, J. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl759 · Cited by 164
Echouffo-Tcheugui, J. B., Narayan, K. M. V., Weisman, D., Golden, S. H., & Jaar, B. G. (2016) · Diabetic Medicine · doi:10.1111/dme.13113 · Cited by 158
Obesity, Metabolic Abnormality, and Progression of CKD
Yun, H., Kim, H., Park, J. T., Chang, T. I., Yoo, T., Kang, S., Choi, K. H., Sung, S. A., Kim, S. W., Lee, J., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.02.362 · Cited by 158
Risk of Chronic and End Stage Kidney Disease in Patients with Nephrolithiasis
Shoag, J. E., Halpern, J. A., Goldfarb, D. S., & Eisner, B. H. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.05.117 · Cited by 153
Metabolically Healthy Obesity and Risk of Incident CKD
Hashimoto, Y., Tanaka, M., Okada, H., Senmaru, T., Hamaguchi, M., Asano, M., Yamazaki, M., Oda, Y., Hasegawa, G., Toda, H., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08980914 · Cited by 156
Metabolic Syndrome and the Development of CKD in American Indians: The Strong Heart Study
Lucove, J. C., Vupputuri, S. X., HEISS, G. M., North, K. E., & Russell, M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.09.014 · Cited by 151
Metabolic syndrome: its history, mechanisms, and limitations
Oda, E. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0309-6 · Cited by 180
Microalbuminuria in HIV infection
Szczech, L. A. M., Grünfeld, C., Scherzer, R., Canchola, J. A., van der Horst, C., Sidney, S., Wohl, D. A., & Shlipak, M. G. (2007) · AIDS · doi:10.1097/qad.0b013e3280d3587f · Cited by 143
Physical Activity and Rapid Decline in Kidney Function Among Older Adults
Robinson‐Cohen, C., Katz, R., Mozaffarian, D., Dalrymple, L. S., de Boer, I. H., Sarnak, M., Shlipak, M., Siscovick, D., & Kestenbaum, B. R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.438 · Cited by 143
Cheng, H.-T., Huang, J.-W., Chiang, C.-K., Yen, C.-J., Hung, K.-Y., & Wu, K.-D. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2658 · Cited by 140
Whaley‐Connell, A. T., & Sowers, J. R. (2017) · Kidney International · doi:10.1016/j.kint.2016.12.034 · Cited by 143
A Simple Algorithm to Predict Incident Kidney Disease
Kshirsagar, A. V., Bang, H., Bomback, A. S., Vupputuri, S. X., Shoham, D. A., Kern, L. M., Klemmer, P. J., Mazumdar, M., & August, P. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.22.2466 · Cited by 137
Wuerzner, G., Pruijm, M. T., Maillard, M. P., Bovet, P., Renaud, C. J., Burnier, M., & Bochud, M. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.03.017 · Cited by 135
Obesity‐related glomerulopathy: Current approaches and future perspectives
Martínez‐Montoro, J. I., Morales, E., Cornejo-Pareja, I. M., Tinahones, F. J., & Fernández‐García, J. C. (2022) · Obesity Reviews · doi:10.1111/obr.13450 · Cited by 133
Han, H., Zhu, J., Zhu, Z., Ni, J., Du, R., Dai, Y., Chen, Y., Wu, Z., Lu, L., & Zhang, R. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001852 · Cited by 131
Sorensen, M. D., Chi, T., Shara, N. M., Wang, H., Hsi, R. S., Orchard, T., Kahn, A., Jackson, R. D., Miller, J., Reiner, A. P., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050548 · Cited by 146
Kollerits, B., Fliser, D., Heid, I. M., Ritz, E., Kronenberg, F., & for the MMKD Study Group (2007) · Kidney International · doi:10.1038/sj.ki.5002191 · Cited by 128
Evidence-based Practice Guideline for the Treatment of CKD
(2009) · Clinical and Experimental Nephrology · doi:10.1007/s10157-009-0237-8 · Cited by 129
Metabolic Syndrome and Risk of Developing Chronic Kidney Disease in Japanese Adults
Tozawa, M., Iseki, C., Tokashiki, K., Chinen, S., Kohagura, K., Kinjo, K., Takishita, S., & Iseki, K. (2007) · Hypertension Research · doi:10.1291/hypres.30.937 · Cited by 124
Nagata, M., Ninomiya, T., Doi, Y., Yonemoto, K., Kubo, M., Hata, J., Tsuruya, K., Iida, M., & Kiyohara, Y. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq062 · Cited by 123
Bonnet, F., Marre, M., Halimi, J., Stengel, B., Lange, C., Laville, M., Tichet, J., & Balkau, B. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000226206.03560.ac · Cited by 124
Straznicky, N. E., Grima, M. T., Lambert, É., Eikelis, N., Dawood, T., Lambert, G. W., Nestel, P. J., Masuo, K., Sari, C. I., Chopra, R., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283418875 · Cited by 129
The Role of Overweight and Obesity in the Cardiorenal Syndrome
Sowers, J. R., Whaley‐Connell, A. T., & Hayden, M. R. (2011) · Cardiorenal Medicine · doi:10.1159/000322822 · Cited by 122
Thorn, L. M., Forsblom, C. M., Wadén, J., Saraheimo, M., Tolonen, N., Hietala, K., Groop, P., & for the Finnish Diabetic Nephropathy (FinnDiane) Study Group (2009) · Diabetes Care · doi:10.2337/dc08-2022 · Cited by 122
Johnson, D. W., Armstrong, K. A., Campbell, S. B., Mudge, D. W., Hawley, C. M., Coombes, J. S., Prins, J. B., & Isbel, N. M. (2007) · Nephrology · doi:10.1111/j.1440-1797.2007.00804.x · Cited by 120
Whaley‐Connell, A. T., Sowers, J. R., McCullough, P. A., Roberts, T. L., McFarlane, S. I., Chen, S., Li, S., Wang, C., Collins, A. J., & Bakris, G. L. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.01.004 · Cited by 119
Jang, H. R., Kang, D., Sinn, D. H., Gu, S., Cho, S. J., Lee, J. E., Huh, W., Paik, S. W., Ryu, S., Chang, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23014-0 · Cited by 120
Solini, A., Menini, S., Rossi, C., Ricci, P. C., Santini, E., Fantauzzi, C. B., Iacobini, C., & Pugliese, G. (2013) · The Journal of Pathology · doi:10.1002/path.4237 · Cited by 125
Metabolic syndrome and renal disease
Gluba-Brzózka, A., Mikhailidis, D. P., Lip, G. Y. H., Hannam, S., Rysz, J., & Banach, M. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.013 · Cited by 120
A Prediction Model for the Risk of Incident Chronic Kidney Disease
Chien, K., Lin, H., Lee, B., Hsu, H., Lee, Y., & Chen, M.-F. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.05.010 · Cited by 113
Kidney Pathological Changes in Metabolic Syndrome: A Cross-sectional Study
Alexander, M. P., Patel, T. V., Farag, Y. M. K., Flórez, A., Rennke, H. G., & Singh, A. K. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.01.255 · Cited by 118
The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort
Kitiyakara, C., Yamwong, S., Cheepudomwit, S., Domrongkitchaiporn, S., Unkurapinun, N., Pakpeankitvatana, V., & Sritara, P. (2007) · Kidney International · doi:10.1038/sj.ki.5002128 · Cited by 107
de Vinuesa, S. G., Goicoechea, M., Kanter, J., Puerta, M., Cachofeiro, V., Lahera, V., Gómez-Campderá, F. J., & Luño, J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080916 · Cited by 107
Obesity, metabolic health, and the risk of end-stage renal disease
Panwar, B., Hanks, L. J., Tanner, R. M., Muntner, P., Kramer, H., McClellan, W. M., Warnock, D. G., Judd, S. E., & Gutiérrez, O. M. (2014) · Kidney International · doi:10.1038/ki.2014.384 · Cited by 112
Renal Disease in Obesity: The Need for Greater Attention
Rutkowski, P., Klassen, A., Šebeková, K., Bahner, U., & Heidland, A. (2006) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2006.04.017 · Cited by 103
Lipid and lipoprotein metabolism in chronic kidney disease.
Kaysen, G. A. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2008.10.011 · Cited by 102
Huh, J. H., Yadav, D., Kim, J. S., Son, J., Choi, E. H., Kim, S. H., Shin, C., Sung, K., & Kim, J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.11.003 · Cited by 108
The serum anion gap is altered in early kidney disease and associates with mortality
Abramowitz, M. K., Hostetter, T. H., & Melamed, M. L. (2012) · Kidney International · doi:10.1038/ki.2012.196 · Cited by 100
Insulin Resistance and Protein Energy Metabolism in Patients with Advanced Chronic Kidney Disease
Siew, E. D., & Ikizler, T. A. (2010) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2010.00763.x · Cited by 99
Nlrp3 is a key modulator of diet-induced nephropathy and renal cholesterol accumulation
Bakker, P. J., Butter, L. M., Kors, L., Teske, G. J. D., Aten, J., Sutterwala, F. S., Florquin, S., & Leemans, J. C. (2013) · Kidney International · doi:10.1038/ki.2013.503 · Cited by 99
Antiobesity effects of Kaempferia parviflora in spontaneously obese type II diabetic mice
Akase, T., Shimada, T., Terabayashi, S., Ikeya, Y., Sanada, H., & Aburada, M. (2010) · Journal of Natural Medicines · doi:10.1007/s11418-010-0461-2 · Cited by 98
Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study
Kronborg, J. B., Solbu, M. D., Njølstad, I., Toft, I., Eriksen, B. O., & Jenssen, T. G. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn148 · Cited by 98
Is Serum Cystatin-C a Reliable Marker for Metabolic Syndrome?
Servais, A., Giral, P., Bernard, M., Bruckert, É., Deray, G., & Bagnis, C. I. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.01.040 · Cited by 97
Iseki, K., Tohyama, K., Matsumoto, T., & Nakamura, H. (2008) · Hypertension Research · doi:10.1291/hypres.31.249 · Cited by 97
The metabolic syndrome and chronic kidney disease
Peralta, C. A., Tamura, M. K., Lo, J. C.-M., & Chertow, G. M. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000232875.27846.7e · Cited by 94
Self-citationThe Enlarging Body of Evidence: Obesity and Chronic Kidney Disease
Chertow, G. M., Hsu, C., & Johansen, K. L. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040327 · Cited by 93
Self-citationImpact of Obesity in Kidney Diseases
Kotsis, V., Martínez, F., Trakatelli, C., & Redón, J. (2021) · Nutrients · doi:10.3390/nu13124482 · Cited by 100
Schrauben, S. J., Jepson, C., Hsu, J. Y., Wilson, F. P., Zhang, X., Lash, J. P., Robinson, B. M., Townsend, R. R., Chen, J., Fogelfeld, L., et al. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1220-6 · Cited by 90
Ryu, S., Chang, Y., Woo, H., Lee, K., Kim, S., Kim, D., Kim, W. S., Suh, B.-S., Jeong, C., & Yoon, K. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.07.027 · Cited by 90
Zoccali, C., Kramer, A., & Jager, K. J. (2009) · Clinical Kidney Journal · doi:10.1093/ndtplus/sfp127 · Cited by 106
Ma, C., Kang, L.-L., Ren, H., Zhang, D., & Kong, L. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.06.015 · Cited by 89
Gerchman, F., Tong, J., Utzschneider, K. M., Zraika, S., Udayasankar, J., McNeely, M. J., Carr, D. B., Leonetti, D. L., Young, B. A., de Boer, I. H., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2508 · Cited by 88
Wu, D., Gao, L., Huang, O., Ullah, K., Guo, M., Liu, Y., Zhang, J., Chen, L., Fan, J., Sheng, J., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14252 · Cited by 87
Childhood Obesity and the Metabolic Syndrome
Nehus, E. J., & Mitsnefes, M. M. (2018) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2018.08.004 · Cited by 91
Metadata
- Authors
- Kurella, M., Lo, J. C., & Chertow, G. M.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-07
- Volume
- 16
- Issue
- 7
- Pages
- 2134-2140
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2107279414
- Cited by
- 709
- References
- 43
- Citations by year
- 2026: 5 · 2025: 18 · 2024: 23 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 34 · 2019: 30 · 2018: 29 · 2017: 24 · 2016: 31 · 2015: 35 · 2014: 45 · 2013: 42 · 2012: 42
- FWCI
- 27.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (N01DK12450)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K12AR047659, K12 AR47659)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- metabolic syndrome, chronic kidney disease, non-diabetic adults, estimated glomerular filtration rate, incident CKD risk, Atherosclerosis Risk in Communities Study, diabetes mellitus, hypertension, cardiovascular risk factors
- MeSH terms
- Chronic Disease, Diabetes Mellitus, Female, Humans, Kidney Diseases, Male, Middle Aged, Risk Factors, Incidence, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.